ЛАБОРАТОРНАЯ МЕДИЦИНА — ФУНДАМЕНТ СОВРЕМЕННОЙ ТЕРАПЕВТИЧЕСКОЙ КЛИНИКИ
https://doi.org/10.20514/2226-6704-2014-0-5-52-53
Abstract
Analytical reliability and clinical significance of laboratory data allows to consider them as a basis for diagnosis and treatment monitoring in therapeutic clinic. Laboratory biomarkers and predictors of use for risk assessment in clinical practice and disease prevention. Pre- and postanalytical stages of laboratory studies a large proportion of errors related to the actions of clinicians. Clinical laboratory diagnostics as a branch of medical science and the element of the health care system evolves, and this requires constant updating of knowledge in the discipline.
About the Author
Л. П. Ефимова
ГБОУ ВПО «Сургутский государственный университет ХМАО-Югры»
Russian Federation
кафедра кардиологии, г. Сургут
Russian Federation
кафедра кардиологии, г. Сургут
References
1. Биомаркёры в лабораторной диагностике / Под ред. В.В. Долгова, О.П. Шевченко, А.О. Шевченко. М.: Триада, 2014. 288 с.
2. Клинический диагноз — лабораторные основы / Под ред. В.В. Меньшикова. М.: Лабинформ, 1997. 320 с.
3. Лаборатория в современной клинике. Взгляд ведущих клиницистов России / Под ред. В.В. Меньшикова. М.: Лабора, 2010. 179 с.
4. Dayer E., Dayer J. M., Roux-Lombard P. Primer: the practical use of biological markers of rheumatic and systemic inflammatory diseases // Nature Clinical Practice Rheumatology. 2007. Vol. 3, № 9. P. 512–520.
5. Harbath S. et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis // Am. J. of Respirat. and Critical Care Medicine. 2001. Vol. 164, № 3. P. 396–402.
6. Hollensead S.C., Lockwood W.B., Elin R.J. Errors in pathology and laboratory medicine: consequences and prevention // J. of Surg. Oncol. 2004. Vol. 88, № 3. P. 161–181.
7. Nutting P.A. et al. Problems in laboratory testing in primary care // Jama. 1996. Vol. 275, № 8. P. 635–639.
8. Pearson T.A. et al. Markers of inflammation and cardiovascular disease application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American heart association // Circulation. 2003. Vol. 107, № 3. P. 499–511.
9. Plebani M. Errors in clinical laboratories or errors in laboratory medicine? // Clin. Chem. Labor. Medicine. 2006. Vol. 44, № 6. P. 750–759.
10. Plebani M. The detection and prevention of errors in laboratory medicine // Annals of clinical biochemistry. 2010. Vol. 47, № 2. P. 101–110.
11. Richardson C., Emery P. Laboratory markers of disease activity // J. of Rheumatology. Suppl. 1996. Vol. 44. P. 23–30.
12. Rosenberg W. et al. Serum markers detect the presence of liver fibrosis: a cohort study // Gastroenterology. 2004. Vol. 127, № 6. P. 1704–1713.
13. Smolen J.S. et al. The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now? // Arthritis Research and Therapy. 2008. Vol. 10, № 3. P. 208.
14. Tibble J. A. et al. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease //Gastroenterology. – 2002. – Т. 123. – №. 2. – С. 450-460.
Review
For citations:
Ефимова Л.П. ЛАБОРАТОРНАЯ МЕДИЦИНА — ФУНДАМЕНТ СОВРЕМЕННОЙ ТЕРАПЕВТИЧЕСКОЙ КЛИНИКИ. The Russian Archives of Internal Medicine. 2014;(5):52-53. (In Russ.) https://doi.org/10.20514/2226-6704-2014-0-5-52-53
Views:
634
Email this article 